Co-expression of multiple transgenes in mouse CNS: a comparison of strategies
- PMID: 11337275
- DOI: 10.1016/s1389-0344(01)00067-3
Co-expression of multiple transgenes in mouse CNS: a comparison of strategies
Abstract
The introduction of two transgenes into one animal is increasingly common as transgenic experiments become more sophisticated. In this study we examine two strategies for creating double transgenic founders from a single microinjection. In the first approach, two constructs, each with its own promoter element, were coinjected into the pronucleus. In the second approach, both transgenes were cloned into one vector, separated by an internal ribosomal entry site (IRES), and placed under control of a single promoter. Both strategies save time and increase the percentage of double transgenic offspring over the standard method of mating single transgenic lines. However, despite high transgene copy numbers, the bicistronic lines did not show robust expression of either protein. Copy number and protein expression correlated much better in the coinjected lines, with expression levels in one line approaching that observed in some of our best single transgenic controls. Thus we recommend coinjection of individual plasmids for the generation of multiply transgenic founders.
Similar articles
-
A vector for expressing foreign genes in the brains and hearts of transgenic mice.Genet Anal. 1996 Dec;13(6):159-63. doi: 10.1016/s1050-3862(96)00167-2. Genet Anal. 1996. PMID: 9117892
-
Neurodegenerative changes associated with beta-amyloid deposition in the brains of mice carrying mutant amyloid precursor protein and mutant presenilin-1 transgenes.Exp Neurol. 2001 Sep;171(1):59-71. doi: 10.1006/exnr.2001.7717. Exp Neurol. 2001. PMID: 11520121
-
Amyloid phenotype characterization of transgenic mice overexpressing both mutant amyloid precursor protein and mutant presenilin 1 transgenes.Neurobiol Dis. 1999 Aug;6(4):231-44. doi: 10.1006/nbdi.1999.0243. Neurobiol Dis. 1999. PMID: 10448051
-
Transgenic mouse models of Alzheimer's disease.Biochem Soc Trans. 1998 Aug;26(3):504-8. doi: 10.1042/bst0260504. Biochem Soc Trans. 1998. PMID: 9765905 Review. No abstract available.
-
Progress toward valid transgenic mouse models for Alzheimer's disease.Neurobiol Aging. 1999 Mar-Apr;20(2):201-11. doi: 10.1016/s0197-4580(99)00042-1. Neurobiol Aging. 1999. PMID: 10537029 Review.
Cited by
-
Microglia use TAM receptors to detect and engulf amyloid β plaques.Nat Immunol. 2021 May;22(5):586-594. doi: 10.1038/s41590-021-00913-5. Epub 2021 Apr 15. Nat Immunol. 2021. PMID: 33859405 Free PMC article.
-
Treatment with D3 removes amyloid deposits, reduces inflammation, and improves cognition in aged AβPP/PS1 double transgenic mice.J Alzheimers Dis. 2013;34(3):609-20. doi: 10.3233/JAD-121792. J Alzheimers Dis. 2013. PMID: 23271316 Free PMC article.
-
Age-Dependent and Aβ-Induced Dynamic Changes in the Subcellular Localization of HMGB1 in Neurons and Microglia in the Brains of an Animal Model of Alzheimer's Disease.Cells. 2024 Jan 18;13(2):189. doi: 10.3390/cells13020189. Cells. 2024. PMID: 38247880 Free PMC article.
-
Immune-mediated platelet depletion augments Alzheimer's disease neuropathological hallmarks in APP-PS1 mice.Aging (Albany NY). 2023 Feb 1;15(3):630-649. doi: 10.18632/aging.204502. Epub 2023 Feb 1. Aging (Albany NY). 2023. PMID: 36734880 Free PMC article.
-
Systemic inflammation impairs microglial Aβ clearance through NLRP3 inflammasome.EMBO J. 2019 Sep 2;38(17):e101064. doi: 10.15252/embj.2018101064. Epub 2019 Jul 30. EMBO J. 2019. PMID: 31359456 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases